Effect of Nano-curcumin on insulin resistance and serum levels of Afamin in patients with metabolic syndrome

Phase 2

Recruiting

• Conditions: Metabolic syndrome.; Metabolic syndrome; E88.81

• Registration Number: IRCT20120215009014N277
• Lead Sponsor: Hamedan University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 21 May 2019

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 60

Inclusion Criteria

Age of 18 to 65 years
Metabolic syndrome

Exclusion Criteria

Diabetes
Thyroid disease
Liver disease
Renal disease

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Measuring the serum levels of Afamin. Timepoint: Before the intervention and 2 months after the intervention. Method of measurement: Through laboratory test.;Measuring the serum levels of insulin. Timepoint: Before the intervention and 2 months after the intervention. Method of measurement: Through laboratory test.